PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 22, 2024Cancer Research0 citations

Abstract 5667: Intratumoral heterogeneity in gastric cancer related with survival and tumor microenvironment

View Full Paper
DGD. GuWKWoo Sun KwonSRSun Young Rha

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract Gastric cancer (GC), often diagnosed at an advanced stage, poses a significant therapeutic challenge due to its resistance to treatment. The understanding of intratumoral heterogeneity, crucial for tumor cell survival, remains limited in GC. We conducted a comprehensive analysis of three patient groups (intraperitoneal metastasis IM, hematogenous metastasis HM, and both metastasis HIM) undergoing immunotherapy (IO) and chemotherapy. Utilizing single-cell RNA sequencing and TCR sequencing, we examined 11 adjacent normal, 10 HM, 8 IM, and 5 HIM primary GC samples. In epithelial cells, three distinct tumor clusters (Tumor₁, Tumor₂, and Tumor₃) were identified. Trajectory analysis revealed the differentiation of chief cells into Tumor₁, subsequently dividing into more malignant cell types, Tumor₂ and Tumor₃. Tumor₂ was enriched in IM, while Tumor₁ was enriched in HM and HIM. Patients grouped by Tumor₁, 2, 3 levels showed varying survival outcomes. Surprisingly, high Tumor₂ levels correlated with increased survival, attributed to elevated HLA and PDL1 expression, promoting immune cell recruitment and robust response to IO therapy. Conversely, Tumor₃ high patients exhibited worse survival, with enrichment in metabolic pathways associated with glycolysis and hypoxia, linking to metastasis. We observed the proportion of T cells that increased presence of CD8 effector cells among patients exhibiting high levels of Tumor₁ and Tumor₂. Through TCR analysis, we found heightened clonality in both CD8 effector cells and exhausted T cells in patients with elevated Tumor₁ and Tumor₂ levels. This suggests that the activated CD8 effector T cells in these patients may enhance their ability to effectively target and attack cancer cells. In summary, this study provides a comprehensive picture of intratumoral heterogeneity in GC can impact the survival and tumor microenvironment. The unexpected high survival in Tumor₂ patients emphasizes the potential of targeting specific pathways for improved therapeutic outcomes. Additionally, the observed T cell dynamics and clonality in Tumor₁ and 2 underscore the importance of understanding the immune microenvironment for effective cancer attack. Citation Format: Do-eon Gu, Woo Sun Kwon, Sun Young Rha, Woong-Yang Park. Intratumoral heterogeneity in gastric cancer related with survival and tumor microenvironment abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts) ; 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (6Suppl): Abstract nr 5667.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gu et al. (2024) studied this question.

synapsesocial.com/papers/68e72e1db6db6435876a72b8https://doi.org/10.1158/1538-7445.am2024-5667
Ask AI
Helpful
Bookmark
Share
View Full Paper